New facial papules in a 66-year-old woman with bladder cancer.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 25108634.
- Also identified by DOI 10.1016/j.jaad.2014.07.012 and PMC identifier 4253599.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Muir-Torre Syndrome (MTS) is an autosomal dominant cancer syndrome that results from a mutation in mismatch repair genes. It is characterized by sebaceous neoplasms, keratoacanthomas, and visceral neoplasm(s) affecting the colon, uterus, ovaries, bladder, or other organs. Mismatch repair immunohistochemistry and microsatellite instability testing of sebaceous neoplasms is available to confirm a diagnosis of MTS. Early recognition of cutaneous features of MTS could lead to early diagnosis and prevention of advanced neoplasms in patients and family members.
Medical subject headings
- Facial Neoplasms
- Muir-Torre Syndrome
- Urinary Bladder Neoplasms